Scarica l'app Stockscreener
220.79
2.66%
5.73
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$215.06
Aprire:
$216.4
Volume 24 ore:
1.12M
Relative Volume:
0.56
Capitalizzazione di mercato:
$51.96B
Reddito:
$244.67B
Utile/perdita netta:
$1.68B
Rapporto P/E:
31.77
EPS:
6.9487
Flusso di cassa netto:
$5.51B
1 W Prestazione:
-2.44%
1M Prestazione:
+6.02%
6M Prestazione:
+49.06%
1 anno Prestazione:
+74.15%
Intervallo 1D:
$216.40
$221.72
Intervallo di 1 settimana:
$213.75
$229.15
Portata 52W:
$120.72
$230.81
Cardinal Health Inc Stock (CAH) Company Profile
Nome
Cardinal Health Inc
Settore
Industria
Telefono
(614) 757-3033
Indirizzo
7000 CARDINAL PLACE, DUBLIN, OH
Compare CAH vs MCK, COR, HSIC, AHG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
220.79 | 50.61B | 244.67B | 1.68B | 5.51B | 6.9487 |
|
MCK
Mckesson Corporation
|
934.75 | 112.20B | 397.96B | 4.55B | 9.64B | 34.77 |
|
COR
Cencora Inc
|
360.83 | 68.29B | 325.78B | 1.64B | 3.61B | 8.3139 |
|
HSIC
Henry Schein Inc
|
78.19 | 9.23B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.3801 | 1.23B | 2.22M | -5.63M | -1.68M | -0.24 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-06-03 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-01-08 | Aggiornamento | TD Cowen | Hold → Buy |
| 2025-01-07 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-12-13 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | Ripresa | Mizuho | Outperform |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-02-09 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-12-14 | Iniziato | Wells Fargo | Underweight |
| 2023-07-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-03-31 | Iniziato | Citigroup | Neutral |
| 2023-02-03 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-08-22 | Ripresa | Morgan Stanley | Overweight |
| 2022-05-26 | Downgrade | Barclays | Overweight → Equal Weight |
| 2022-05-18 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-04-12 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | Ripresa | Credit Suisse | Neutral |
| 2021-08-06 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-08-05 | Downgrade | BofA Securities | Buy → Underperform |
| 2021-05-10 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-09-25 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-07-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-05-15 | Aggiornamento | UBS | Neutral → Buy |
| 2020-04-23 | Ripresa | Credit Suisse | Neutral |
| 2020-03-20 | Aggiornamento | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-08-27 | Downgrade | Argus | Buy → Hold |
| 2019-08-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-04-18 | Iniziato | Guggenheim | Neutral |
| 2019-01-17 | Iniziato | UBS | Neutral |
| 2018-11-16 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | Aggiornamento | Argus | Hold → Buy |
| 2018-03-08 | Iniziato | Barclays | Equal Weight |
| 2018-02-27 | Ripresa | BofA/Merrill | Underperform |
| 2018-01-05 | Iniziato | Evercore ISI | In-line |
Mostra tutto
Cardinal Health Inc Borsa (CAH) Ultime notizie
Cardinal Health’s Broad Profit Growth Raises Questions On Valuation Gap - Yahoo Finance
Cardinal Health Inc (NYSE:CAH) Boosts Logistics Reliability On Nyse Composite Today - Kalkine Media
Cardinal Health (CAH) Valuation Check After Recent Pullback And Strong Long Term Returns - Yahoo Finance
Best Momentum Stock to Buy for February 13th - The Globe and Mail
Cardinal Health, Inc. (NYSE:CAH) to Issue $0.51 Quarterly Dividend - MarketBeat
Cardinal Health's (NYSE:CAH) Solid Earnings Are Supported By Other Strong Factors - Yahoo Finance
LSV Asset Management Reduces Stake in Cardinal Health, Inc. $CAH - MarketBeat
Cookson Peirce & Co. Inc. Sells 7,855 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Caprock Group LLC Makes New $2.25 Million Investment in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health Board of Directors Approves Quarterly Dividend - GuruFocus
Cardinal Health Keeps Quarterly Dividend at $0.5107 per Share, Payable April 15 to Holders of Record April 1 - marketscreener.com
Cardinal Health to pay $0.5107 dividend per share on April 15 - Stock Titan
The 5 Most Interesting Analyst Questions From Cardinal Health’s Q4 Earnings Call - The Globe and Mail
The 5 Most Interesting Analyst Questions From Cardinal Health's Q4 Earnings Call - Finviz
Cardinal Health Inc (NYSE:CAH): A GARP Stock with Affordable Growth and Reasonable Valuation - ChartMill
Cardinal Health (NYSE:CAH) Given New $248.00 Price Target at Argus - MarketBeat
ING Groep NV Sells 77,635 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Wells Fargo Raises Price Target for Cardinal Health (CAH) | CAH Stock News - GuruFocus
Cardinal Health (NYSE:CAH) Given New $243.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Nasogastric Tubes Market Is Booming Worldwide 2026-2033 | - openPR.com
Wells Fargo Adjusts Price Target on Cardinal Health to $256 From $237, Maintains Overweight Rating - marketscreener.com
Candriam S.C.A. Acquires 19,155 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Fresh Look At Cardinal Health (CAH) Valuation After Mixed Recent Share Performance - Sahm
Earnings Winners: 2 Buy Rated Stocks Raising Guidance - Finviz
Lasix ONYU Gains Major Distributor Access Through Cardinal Health and Cencora - Pharmaceutical Commerce
Morgan Stanley raises Cardinal Health, Inc. (CAH) price target after strong Q2 - MSN
Morgan Stanley Raises Cardinal Health, Inc. (CAH) Price Target After Strong Q2 - Finviz
Cardinal Health CEO Jason Hollar says Central Ohio is key to achieving record revenue - The Business Journals
Cardinal Health, Inc. (CAH) shares gain favor as Citi turns bullish on specialist assets - MSN
Cardinal Health, Inc. (NYSE:CAH) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? - 富途牛牛
Why Cardinal Health (CAH) Is Up 5.3% After Raising Full-Year Earnings Guidance Again And Boosting Buybacks - Yahoo Finance
Cardinal Health price target raised to $255 from $245 at Morgan Stanley - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX) and Cardinal Health (CAH) - The Globe and Mail
Cardinal Health (NYSE:CAH) Price Target Raised to $260.00 - MarketBeat
Cardinal Health, Inc. $CAH Shares Bought by Envestnet Asset Management Inc. - MarketBeat
Cardinal Health Q2 2026 Review: An Epitome Of Resilience And Earnings Power (Upgrade) - Seeking Alpha
Cardinal Health Guidance Hike Sparks Questions On Valuation And Growth Drivers - Sahm
UBS Adjusts Cardinal Health Price Target to $260 From $250, Maintains Buy Rating - marketscreener.com
Cardinal Health (CAH) Receives Rating Update and Price Target In - GuruFocus
Cardinal Health stock hits all-time high at $229.87 By Investing.com - Investing.com Canada
Leerink Partners Raises Cardinal Health (NYSE:CAH) Price Target to $268.00 - MarketBeat
Here's Why Cardinal Health (CAH) is a Strong Momentum Stock - Yahoo Finance
Evercore ISI Adjusts Cardinal Health Price Target to $260 From $250 - marketscreener.com
Mizuho Adjusts Price Target on Cardinal Health to $235 From $222, Maintains Outperform Rating - marketscreener.com
Cardinal Health, Inc. (NYSE:CAH) Q2 2026 Earnings Call Transcript - Insider Monkey
CAH Q4 Deep Dive: Specialty and Growth Segments Drive Outperformance and Upgraded Outlook - Finviz
Cardinal Health Q2 Earnings Call Highlights - MarketBeat
Is Cardinal Health (CAH) Pricing Reflect Its Surge And Role In The Healthcare Supply Chain - Yahoo Finance
Decoding Cardinal Health Inc (CAH): A Strategic SWOT Insight - GuruFocus
Cardinal Health (NYSE:CAH) Exceeds Q4 CY2025 Expectations - The Globe and Mail
Cardinal Health boosts annual profit forecast on surging demand for specialty drugs - 104.1 WIKY
Cardinal Health Inc Azioni (CAH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.78%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):